HCW Biologics Inc (HCWB)
1.03
-0.08
(-7.21%)
USD |
NASDAQ |
Jun 03, 16:00
1.03
0.00 (0.00%)
After-Hours: 20:00
HCW Biologics Price: 1.03 for June 3, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Jun 03, 2024 | 1.08 | 1.09 | 1.02 | 1.09 | 3082.00 |
May 31, 2024 | 1.105 | 1.12 | 1.10 | 1.11 | 2967.00 |
May 30, 2024 | 1.12 | 1.12 | 1.09 | 1.09 | 20957.00 |
May 29, 2024 | 1.10 | 1.14 | 1.10 | 1.10 | 28347.00 |
May 28, 2024 | 1.12 | 1.136 | 1.10 | 1.10 | 15280.00 |
May 24, 2024 | 1.102 | 1.122 | 1.10 | 1.11 | 29200.00 |
May 23, 2024 | 1.10 | 1.10 | 1.10 | 1.10 | 15764.00 |
May 22, 2024 | 1.11 | 1.16 | 1.10 | 1.110 | 17898.00 |
May 21, 2024 | 1.10 | 1.106 | 1.10 | 1.106 | 7322.00 |
May 20, 2024 | 1.100 | 1.14 | 1.10 | 1.11 | 14867.00 |
May 17, 2024 | 1.10 | 1.16 | 1.10 | 1.10 | 20538.00 |
May 16, 2024 | 1.11 | 1.15 | 1.10 | 1.10 | 121983.0 |
May 15, 2024 | 1.21 | 1.22 | 1.12 | 1.16 | 46199.00 |
May 14, 2024 | 1.16 | 1.201 | 1.10 | 1.15 | 13996.00 |
May 13, 2024 | 1.19 | 1.204 | 1.12 | 1.12 | 25591.00 |
May 10, 2024 | 1.16 | 1.29 | 1.12 | 1.13 | 20336.00 |
May 09, 2024 | 1.17 | 1.20 | 1.15 | 1.20 | 8519.00 |
May 08, 2024 | 1.28 | 1.33 | 1.150 | 1.16 | 78051.00 |
May 07, 2024 | 1.30 | 1.30 | 1.28 | 1.28 | 6199.00 |
May 06, 2024 | 1.41 | 1.41 | 1.27 | 1.28 | 4976.00 |
May 03, 2024 | 1.43 | 1.43 | 1.28 | 1.33 | 5751.00 |
May 02, 2024 | 1.40 | 1.40 | 1.32 | 1.32 | 4298.00 |
May 01, 2024 | 1.30 | 1.377 | 1.26 | 1.377 | 2460.00 |
Apr 30, 2024 | 1.45 | 1.550 | 1.290 | 1.40 | 13002.00 |
Apr 29, 2024 | 1.46 | 1.46 | 1.41 | 1.41 | 2213.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.92
Minimum
Nov 15 2023
6.30
Maximum
Jul 20 2021
2.154
Average
2.10
Median
Mar 14 2022
Price Benchmarks
CEL-SCI Corp | 1.22 |
AIM ImmunoTech Inc | 0.353 |
IGC Pharma Inc | 0.49 |
NovaBay Pharmaceuticals Inc | 3.12 |
Protalix BioTherapeutics Inc | 1.17 |
Price Related Metrics
PS Ratio | 9.513 |
PEG Ratio | -0.0261 |
Price to Book Value | 4.457 |
Earnings Yield | -73.79% |
Market Cap | 38.96M |
PEGY Ratio | -0.0261 |